<DOC>
	<DOCNO>NCT00821418</DOCNO>
	<brief_summary>The purpose study assess safety effect treatment PulseHaler™ patient COPD , measure change baseline full pulmonary function , oxygen saturation , exercise tolerance health relate quality life ; assess ease use PulseHaler™ patient .</brief_summary>
	<brief_title>Assessment Treatment With PulseHaler Patients With Chronic Obstructive Pulmonary Disease ( COPD )</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<criteria>Diagnosis COPD Diagnosis establish least 1 year ; Postbronchodilator FEV1/FVC &lt; 0.7 Post bronchodilator FEV1 &lt; 70 % predicted Age : 40 year old Smoking cigarette , least 10PY Patient sign informed consent form Bullous Emphysema ( rule recent CT ) Hospitalization due exacerbation COPD within last 3 month Upper respiratory infection and/or exacerbation COPD last 4 week Systemic steroid treatment last 4 week Women age fertility , pregnant , plan pregnancy , use contraceptive . Severe cardiac disease , e.g. , CHF grade 3 high Acute MI within last 3 month CABG within last 3 month Other severe systemic disease</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>